SARS-CoV-2 infection protects against rechallenge in rhesus macaques

Chandrashekar, Abishek, Liu, Jinyan, Martinot, Amanda J., McMahan, Katherine, Mercado, Noe B., Peter, Lauren, Tostanoski, Lisa H., Yu, Jingyou +45 more·2020·Science
DOI 10.1126/science.abc4776

Cited by (785)

Items 301–400 of 785

  1. CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification.
    A. Okoye, D. Duell, Y. Fukazawa, B. Varco-Merth, A. Marenco, Hannah Behrens, Talent Morgan Chaunzwa, Andrea N. Selseth, Roxanne M. Gilbride, Jason Shao et al. · 2021 · Journal of Clinical Investigation
  2. Modeling recapitulates the heterogeneous outcomes of SARS-CoV-2 infection and quantifies the differences in the innate immune and CD8 T-cell responses between patients experiencing mild and severe symptoms
    Budhaditya Chatterjee, Harshbir Singh Sandhu, Narendra M. Dixit · 2022 · PLoS Pathogens
  3. Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452
    D. Alleva, A. Delpero, M. Scully, Sylaja Murikipudi, Ramya Ragupathy, Emma K. Greaves, Thillainaygam Sathiyaseelan, Jeffrey R. Haworth, Nishit J. Shah, Vidhya Rao et al. · 2021 · Vaccine
  4. Recovery from acute SARS-CoV-2 infection and development of anamnestic immune responses in T cell-depleted rhesus macaques
    K. Hasenkrug, F. Feldmann, Lara M. Myers, Mario L. Santiago, K. Guo, Bradley S. Barrett, Kaylee L. Mickens, A. Carmody, A. Okumura, Deepashri Rao et al. · 2021 · bioRxiv
  5. Durable SARS-CoV-2 B cell immunity after mild or severe disease.
    C. Ogega, Nicole E. Skinner, P. Blair, Han-Sol Park, Kirsten Littlefield, A. Ganesan, S. Dhakal, Pranay Ladiwala, A. Antar, S. Ray et al. · 2021 · Journal of Clinical Investigation
  6. Localized and Systemic Immune Responses against SARS-CoV-2 Following Mucosal Immunization
    S. Chandrasekar, Y. Phanse, Rachel E. Hildebrand, M. Hanafy, Chia-wei Wu, Chungyi H. Hansen, J. Osorio, M. Suresh, A. Talaat · 2021 · Vaccines
  7. Distribution of Droplets and Immune Responses After Aerosol and Intra-Nasal Delivery of Influenza Virus to the Respiratory Tract of Pigs
    Veronica Martini, M. Hinchcliffe, E. Blackshaw, M. Joyce, Adam Mcnee, P. Beverley, A. Townsend, R. Macloughlin, E. Tchilian · 2020 · bioRxiv
  8. Immune correlates of protection for SARS-CoV-2, Ebola and Nipah virus infection
    B. Escudero-Pérez, P. Lawrence, J. Castillo-Olivares · 2023 · Frontiers in Immunology
  9. REGN-COV2 antibody cocktail prevents and treats SARS-CoV-2 infection in rhesus macaques and hamsters
    A. Baum, R. Copin, D. Ajithdoss, An-Bo Zhou, Kathryn Lanza, Nicole Negron, M. Ni, Yi Wei, G. Atwal, A. Oyejide et al. · 2020 · bioRxiv
  10. Comparative Study of Government Response Measures and Epidemic Trends for COVID‐19 Global Pandemic
    Chen-Yang Wang, Hui Zhang, Yang Gao, Qing Deng · 2021 · Risk Analysis
  11. Health systems in the ACT-A
    D. Hipgrave, Aboubacar Kampo, Luwei Pearson · 2021 · The Lancet
  12. Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset
    Varun Sasisekharan, Niharika Pentakota, Akila Jayaraman, Kannan Tharakaraman, G. Wogan, Uma Narayanasami · 2021 · Proceedings of the National Academy of Sciences of the United States of America
  13. Exosome-Mediated mRNA Delivery For SARS-CoV-2 Vaccination
    Shang-Jui Tsai, Chen-Xu Guo, A. Sedgwick, Saravana Kanagavelu, Justin Nice, Sanjana Shetty, Connie Landaverde, Nadia A. Atai, S. Gould · 2020 · bioRxiv
  14. Metformin Suppresses Monocyte Immunometabolic Activation by SARS-CoV-2 Spike Protein Subunit 1
    T. Cory, R. Emmons, Johnathan R. Yarbro, Kierstin L. Davis, Brandt D. Pence · 2021 · Frontiers in Immunology
  15. Brain cross‐protection against SARS‐CoV‐2 variants by a lentiviral vaccine in new transgenic mice
    Min-Wen Ku, Pierre Authié, M. Bourgine, François Anna, Amandine Noirat, Fanny Moncoq, B. Vesin, Fabien Névo, Jodie Lopez, P. Souque et al. · 2021 · EMBO Molecular Medicine
  16. MiRNA Profiling in Plasma and Placenta of SARS-CoV-2-Infected Pregnant Women
    I. Saulle, M. Garziano, C. Fenizia, G. Cappelletti, F. Parisi, M. Clerici, I. Cetin, V. Savasi, M. Biasin · 2021 · Cells
  17. Coronavirus-Specific Antibody Cross Reactivity in Rhesus Macaques following SARS-CoV-2 Vaccination and Infection
    Catherine Jacob-Dolan, Jared E. Feldman, Katherine McMahan, Jingyou Yu, Roland C. Zahn, Frank Wegmann, Hanneke Schuitemaker, Aaron G. Schmidt, Dan H. Barouch · 2021 · Journal of Virology
  18. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray
    D. Camerini, A. Randall, Krista Trappl-Kimmons, Amit Oberai, C. Hung, J. Edgar, A. Shandling, Vu T. Huynh, A. Teng, G. Hermanson et al. · 2021 · medRxiv
  19. Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile.
    J. Law, W. Koh, P. Budylowski, Jonah Lin, Feng Yue, K. Abe, B. Rathod, M. Girard, Zhi-Jie Li, J. Rini et al. · 2020 · Journal of Immunology
  20. Targeting the renin−angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges
    K. Sriram, R. Loomba, P. Insel · 2020 · Proceedings of the National Academy of Sciences of the United States of America
  21. Is Herd Immunity Against SARS-CoV-2 a Silver Lining?
    R. Vignesh, E. Shankar, V. Velu, S. Thyagarajan · 2020 · Frontiers in Immunology
  22. Animal models for SARS‐CoV‐2 infection and pathology
    Zhen-Fei Bi, Wei-Qi Hong, Jing-Yun Yang, Shuai-Yao Lu, Xiao-Zhong Peng · 2021 · MedComm
  23. Commercial Interferon-gamma release assay to assess the immune response to first and second doses of mRNA vaccine in previously COVID-19 infected versus uninfected individuals
    N. Tormo, D. Navalpotro, M. Martínez-Serrano, Marta Moreno, Fernando Grosson, I. Tur, Ma Remedio Guna, P. Soriano, A. Tornero, C. Gimeno · 2021 · Diagnostic microbiology and infectious disease
  24. Antibodies Responses to SARS-CoV-2 in a Large Cohort of Vaccinated Subjects and Seropositive Patients
    Emanuele Amodio, Giuseppina Capra, Alessandra Casuccio, Simona De Grazia, Dario Genovese, Stefano Pizzo, Giuseppe Calamusa, Donatella Ferraro, Anna Giammanco, Francesco Maria Vitale et al. · 2021 · Vaccines
  25. COVID-19 and Pregnancy: Vertical Transmission and Inflammation Impact on Newborns
    M. Joma, Claire-Maelle Fovet, N. Seddiki, P. Gressens, M. Laforge · 2021 · Vaccines
  26. Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques
    Elise G. Viox, T. Hoang, Amit A. Upadhyay, Rayhane Nchioua, M. Hirschenberger, Z. Strongin, G. Tharp, Maria Pino, K. Nguyen, J. Harper et al. · 2022 · bioRxiv
  27. An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa
    B. Vesin, Jodie Lopez, Amandine Noirat, Pierre Authié, I. Fert, F. le Chevalier, Fanny Moncoq, K. Nemirov, C. Blanc, C. Planchais et al. · 2022 · Molecular Therapy
  28. Immune Correlates of COVID-19 Control
    B. Poonia, S. Kottilil · 2020 · Frontiers in Immunology
  29. Reinfection with SARS-CoV-2: Discrete SIR (Susceptible, Infected, Recovered) Modeling Using Empirical Infection Data
    Andrew McMahon, Nicole C. Robb · 2020 · JMIR Public Health and Surveillance
  30. SARS-CoV-2 infection leads to acute infection with dynamic cellular and inflammatory flux in the lung that varies across nonhuman primate species
    D. Singh, Shashank R. Ganatra, Bindu Singh, Journey Cole, Kendra J. Alfson, E. Clemmons, Michal Gazi, O. Gonzalez, Ruby A. Escobedo, Tae-Hyung Lee et al. · 2020 · bioRxiv
  31. PARIS and SPARTA: Finding the Achilles’ Heel of SARS-CoV-2
    Viviana R. Simon, Vamsi K Kota, Ryan F. Bloomquist, Hannah B. Hanley, David Forgacs, Savita G. Pahwa, Suresh Pallikkuth, Loren Gregory Miller, Joanna M. D. Schaenman, Michael R. Yeaman et al. · 2022 · mSphere
  32. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques
    A. White, L. Sibley, C. Sarfas, Alexandra L. Morrison, K. Bewley, C. Churchward, S. Fotheringham, Konstantinos Gkolfinos, K. Gooch, Alastair Handley et al. · 2022 · Frontiers in Immunology
  33. Predicting mammalian species at risk of being infected by SARS-CoV-2 from an ACE2 perspective
    Yulong Wei, P. Aris, Heba Farookhi, X. Xia · 2021 · Scientific Reports
  34. Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2
    N. Taefehshokr, Sina Taefehshokr, B. Heit · 2020 · Pathogens
  35. Friends or foes? The knowns and unknowns of natural killer cell biology in COVID-19 and other coronaviruses in July 2020
    C. Manickam, S. Sugawara, R. K. Reeves · 2020 · PLoS Pathogens
  36. Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2
    Petra Mooij, Juan García‐Arriaza, Patricia Pérez, Adrián Lázaro-Frías, Babs E. Verstrepen, Kinga P. Böszörményi, Daniëlla Mortier, Zahra C. Fagrouch, Gwendoline Kiemenyi-Kayere, Henk Niphuis et al. · 2022 · Frontiers in Immunology
  37. Seroprevalence of SARS-CoV-2 in Bhubaneswar, India: findings from three rounds of community surveys
    J. Kshatri, D. Bhattacharya, I. Praharaj, Asit Mansingh, D. Parai, S. Kanungo, S. K. Palo, S. Giri, Matrujyoti Pattnaik, Shakti Ranjan Barik et al. · 2021 · Epidemiology and Infection
  38. Transmission and Protection against Reinfection in the Ferret Model with the SARS-CoV-2 USA-WA1/2020 Reference Isolate
    D. Patel, C. Field, K. M. Septer, D. Sim, Matthew J. Jones, T. Heinly, T. Vanderford, E. McGraw, T. Sutton · 2021 · Journal of Virology
  39. Cell-type apoptosis in lung during SARS-CoV-2 infection
    Ya-Kun Liu, Tania M Garron, Q. Chang, Zhengchen Su, Changcheng Zhou, Eric C. Gong, Jun-Ying Zheng, Y. Yin, T. Ksiazek, T. Brasel et al. · 2020 · bioRxiv
  40. Severe acute respiratory syndrome coronavirus‐2 natural animal reservoirs and experimental models: systematic review
    Salma N. Younes, N. Younes, F. Shurrab, Gheyath K Nasrallah · 2020 · Reviews in Medical Virology
  41. TREM2+ and interstitial-like macrophages orchestrate airway inflammation in SARS-CoV-2 infection in rhesus macaques
    Amit A. Upadhyay, Elise G. Viox, T. Hoang, Arun K. Boddapati, Maria Pino, M. Lee, Jacqueline Corry, Z. Strongin, David A. Cowan, Elizabeth N. Beagle et al. · 2023 · Nature Communications
  42. A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells
    Sofia K. Appelberg, G. Ahlén, Jing-Yi Yan, N. Nikouyan, S. Weber, O. Larsson, U. Höglund, Soo Aleman, F. Weber, Emma Perlhamre et al. · 2022 · EMBO Molecular Medicine
  43. Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2
    Ria Lassaunière, C. Polacek, G. Gram, Anders Frische, J. Tingstedt, Maren Krüger, B. Dorner, Anthony Cook, Renita Brown, Tatyana Orekov et al. · 2021 · npj Vaccines
  44. COVID-19 Research: Lessons from Non-Human Primate Models
    Laure Albrecht, Elodie Bishop, Basile Jay, Blaise Lafoux, Marie Minoves, C. Passaes · 2021 · Vaccines
  45. Will achieving herd immunity be a road to success to end the COVID-19 pandemic?
    C. Diméglio, Fabrice Hérin, M. Miédougé, Isabelle Da-Silva, Marion Porcheron, Guillaume Martin-blondel, J. Soulat, J. Izopet · 2021 · Journal of Infection
  46. Longitudinal SARS-CoV-2 antibody study using the Easy Check COVID-19 IgM/IgG™ lateral flow assay
    Renee L Higgins, S. Rawlings, Jamie Case, F. Lee, C. Chan, Bethany L. Barrick, Z. Burger, K. Yeo, D. Marrinucci · 2021 · PLoS ONE
  47. Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat spike protein RBD protects mice against COVID-19
    Kun Xu, Yaling An, Qunlong Li, Wei-Jing Huang, Yuxuan Han, Tianyi Zheng, Fang Fang, Hui Liu, Chuan-Yu Liu, Ping Gao et al. · 2021 · Emerging Microbes and Infections
  48. Simulation of SARS-CoV-2 Aerosol Emissions in the Infected Population and Resulting Airborne Exposures in Different Indoor Scenarios
    M. Riediker, C. Monn · 2020 · Aerosol and Air Quality Research
  49. The Interaction of Natural and Vaccine-Induced Immunity with Social Distancing Predicts the Evolution of the COVID-19 Pandemic
    M. Good, M. Hawkes · 2020 · mBio
  50. Reinfection of COVID-19 in Pakistan: A First Case Report
    Muhammad Hanif, M. A. Haider, M. J. Ali, S. Naz, Fnu Sundas · 2020 · Cureus
  51. SARS-CoV-2 Vaccine Development: An Overview and Perspectives
    Yi Liu, Kai Wang, T. Massoud, R. Paulmurugan · 2020 · ACS Pharmacology & Translational Science
  52. The starting line for COVID-19 vaccine development
    N. Lee, A. McGeer · 2020 · The Lancet
  53. Evaluation of the Levels of Peripheral CD3+, CD4+, and CD8+ T Cells and IgG and IgM Antibodies in COVID-19 Patients at Different Stages of Infection
    Waleed Aljabr, Ahod Al-Amari, B. Abbas, A. Karkashan, Saad Alamri, Mohammed Alnamnakani, Athba Al-Qahtani · 2022 · Microbiology spectrum
  54. Modeling SARS-CoV-2: Comparative Pathology in Rhesus Macaque and Golden Syrian Hamster Models
    S. Choudhary, Isis Kanevsky, S. Yıldız, R. Sellers, K. Swanson, Tania Franks, Raveen Rathnasinghe, Raquel Muñoz-Moreno, S. Jangra, O. Gonzalez et al. · 2022 · Toxicologic pathology (Print)
  55. Diversity of Coronaviruses with Particular Attention to the Interspecies Transmission of SARS-CoV-2
    A. Shehata, Y. Attia, M. Rahman, S. Basiouni, H. El-Seedi, E. Azhar, A. Khafaga, H. Hafez · 2022 · Animals
  56. SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques
    R. Roozendaal, L. Solforosi, Daniel J. Stieh, J. Serroyen, R. Straetemans, Anna Dari, M. Boulton, F. Wegmann, S. R. Rosendahl Huber, J. V. D. van der Lubbe et al. · 2021 · Nature Communications
  57. Overview of Nonhuman Primate Models of SARS-CoV-2.
    A. Trichel · 2021 · Comparative medicine
  58. IgG Antibodies Generation and Side Effects Caused by Ad5-nCoV Vaccine (CanSino Biologics) and BNT162b2 Vaccine (Pfizer/BioNTech) among Mexican Population
    Oscar Guzmán-Martínez, Kathia Guardado, Elsa Ladrón de Guevara, Saturnino Mezcua Navarro, Crescencio Hernández, Roberto Zenteno‐Cuevas, Hilda Montero · 2021 · Vaccines
  59. A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: Proposals for better quality of CCP collections
    S. Wendel, R. Fontão-Wendel, R. Fachini, G. Candelaria, P. Scuracchio, R. Achkar, M. Brito, L. F. Reis, A. Camargo, M. Amano et al. · 2021 · Transfusion
  60. DNA-launched RNA replicon vaccines induce potent anti-SARS-CoV-2 immune responses in mice
    I. Szurgot, L. Hanke, D. Sheward, L. P. Vidakovics, B. Murrell, G. Mcinerney, P. Liljeström · 2021 · Scientific Reports
  61. Bioengineered in Vitro Tissue Models to Study SARS-CoV-2 Pathogenesis and Therapeutic Validation
    Juhi Chakraborty, Indranil Banerjee, Raju Vaishya, Sourabh Ghosh · 2020 · ACS Biomaterials Science & Engineering
  62. Remarkable immunogenicity and protective efficacy of BBV152, an inactivated SARS-CoV-2 vaccine in rhesus macaques
    P. Yadav, Raches Ella, Sanjay Kumar, Dilip R Patil, S. Mohandas, A. Shete, Gaurav Bhati, G. Sapkal, H. Kaushal, Savita Patil et al. · 2020 · Research Square
  63. Intranasal delivery of a rationally attenuated SARS-CoV-2 is immunogenic and protective in Syrian hamsters
    Shu-Feng Liu, C. Stauft, Prabhuanand Selvaraj, P. Chandrasekaran, F. D'agnillo, Chao-Kai Chou, Wells W. Wu, Christopher Z. Lien, Clement A. Meseda, Cyntia L Pedro et al. · 2022 · Nature Communications
  64. Prior infection with SARS-CoV-2 WA1/2020 partially protects rhesus macaques against reinfection with B.1.1.7 and B.1.351 variants
    A. Chandrashekar, Jin-Yan Liu, Jing-You Yu, K. McMahan, Lisa H. Tostanoski, Catherine Jacob-Dolan, N. Mercado, Tochi Anioke, Aiquan Chang, Sarah Gardner et al. · 2021 · Science Translational Medicine
  65. Intradermal-delivered DNA vaccine induces durable immunity mediating a reduction in viral load in a rhesus macaque SARS-CoV-2 challenge model
    Ami R. Patel, Jewell N. Walters, E. Reuschel, K. Schultheis, Elizabeth M. Parzych, E. Gary, I. Maričić, M. Purwar, Zeena Eblimit, Susanne N. Walker et al. · 2021 · Cell Reports Medicine
  66. Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV-2 infected macaques
    K. V. van Rompay, K. Olstad, R. Sammak, Joseph C. Dutra, Jennifer K. Watanabe, J. Usachenko, Ramya Immareddy, A. Verma, Yashavanth Shaan Lakshmanappa, B. Schmidt et al. · 2021 · PLoS Pathogens
  67. Animal Models of COVID-19 II. Comparative Immunology
    R. Veenhuis, C. Zeiss · 2021 · ILAR journal
  68. The Mechanisms and Animal Models of SARS-CoV-2 Infection
    Wenrui Jia, Juan Wang, Bao Sun, J. Zhou, Yamin Shi, Zheng Zhou · 2021 · Frontiers in Cell and Developmental Biology
  69. Bridging animal and clinical research during SARS-CoV-2 pandemic: A new-old challenge
    M. Winkler, T. Skirecki, F. Brunkhorst, S. Cajander, J. Cavaillon, R. Ferrer, S. Flohé, A. García-Salido, E. Giamarellos-Bourboulis, M. Girardis et al. · 2021 · EBioMedicine
  70. Potential Therapeutic Effect of Traditional Chinese Medicine on Coronavirus Disease 2019: A Review
    Qin Qiu, Yu-Ge Huang, Xiaohua Liu, Fangfang Huang, Xiao-Ling Li, L. Cui, Hui Luo, Lian-Xiang Luo · 2020 · Frontiers in Pharmacology
  71. Animal Models of Long Covid: A Hit-and-Run Disease
    A. Schäfer, S. Leist, John M. Powers, R. Baric · 2024 · Science Translational Medicine
  72. Reinfections in COVID-19 Patients: Impact of Virus Genetic Variability and Host Immunity
    Aisha D. Fakhroo, Hebah A. Al-Khatib, Asmaa A. Al Thani, Hadi Mohamad Yassine · 2021 · Vaccines
  73. COVID-19–Associated Acute Respiratory Distress Syndrome
    Elizabeth A. Middleton, G. Zimmerman · 2021 · Critical care clinics
  74. Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2: What Goes Around May Come Back Around
    A. Kim, R. Gandhi · 2020 · Clinical Infectious Diseases
  75. Frontiers in the COVID-19 vaccines development
    Ehtisham Ul Haq, Ji-Feng Yu, Jian-Cheng Guo · 2020 · Experimental Hematology & Oncology
  76. Development of animal models for emerging infectious diseases by breaking the barrier of species susceptibility to human pathogens
    Na Rong, Jiang-Ning Liu · 2023 · Emerging Microbes and Infections
  77. After the virus has cleared—Can preclinical models be employed for Long COVID research?
    Ethan B. Jansen, S. N. Orvold, C. Swan, Anthony Yourkowski, Brittany Thivierge, Magen E. Francis, Anni Ge, Melissa L. Rioux, Joseph Darbellay, J. Howland et al. · 2022 · PLoS Pathogens
  78. Performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the QuantiFERON® SARS-CoV-2 test for detection and quantification of SARS-CoV-2-Spike-reactive-IFN-γ-producing T cells after COVID-19 vaccination
    N. Tormo, E. Giménez, M. Martínez-Navarro, E. Albert, D. Navalpotro, I. Torres, C. Gimeno, D. Navarro · 2022 · European Journal of Clinical Microbiology and Infectious Diseases
  79. Rapid Assessment of Binding Affinity of SARS-COV-2 Spike Protein to the Human Angiotensin-Converting Enzyme 2 Receptor and to Neutralizing Biomolecules Based on Computer Simulations
    D. Buratto, A. Saxena, Qun Ji, Guang Yang, Sergio Pantano, F. Zonta · 2021 · Frontiers in Immunology
  80. ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models
    T. Lambe, Alexandra J. Spencer, Kelly M. Thomas, K. Gooch, Stephen R. Thomas, A. White, H. Humphries, Daniel Wright, Sandra Belij-Rammerstorfer, Nazia Thakur et al. · 2021 · Communications Biology
  81. Development of SARS-CoV-2 vaccines: challenges, risks, and the way forward
    V. Vashishtha, Puneet Kumar · 2020 · Human Vaccines & Immunotherapeutics
  82. Viruses That Can and Cannot Coexist With Humans and the Future of SARS-CoV-2
    Y. Furuse, H. Oshitani · 2020 · Frontiers in Microbiology
  83. Antibody-dependent enhancement and COVID-19: Moving toward acquittal
    Eric J. Yager · 2020 · Clinical Immunology
  84. Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial
    Hana M. El Sahly, Lindsey Robert Baden, Brandon J. Essink, David C. Montefiori, Adrian McDermont, Richard E. Rupp, Michael Lewis, Shobha Swaminathan, Carl Griffin, Veronica G. Fragoso et al. · 2022 · The Journal of Infectious Diseases
  85. A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2–specific immune responses in rhesus macaques
    Xuan He, Malika Aid, A. Chandrashekar, Jing-You Yu, K. McMahan, F. Wegmann, Catherine Jacob-Dolan, Jenny S. Maron, C. Atyeo, Hua-Hua Wan et al. · 2022 · Science Translational Medicine
  86. A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques
    Ronald R. Cobb, Joseph P. Nkolola, P. Gilchuk, A. Chandrashekar, Jing-You Yu, R. House, C. Earnhart, N. Dorsey, S. Hopkins, Doris M. Snow et al. · 2022 · i Medicina
  87. Medical imaging of pulmonary disease in SARS-CoV-2-exposed non-human primates
    M. Stammes, J. Lee, L. Meijer, Thibaut Naninck, L. Doyle-Meyers, Alexander G. White, H. Borish, A. Hartman, X. Alvarez, Shashank R. Ganatra et al. · 2021 · Trends in Molecular Medicine
  88. Characterization of SARS-CoV-2 and host entry factors distribution in a COVID-19 autopsy series
    Xiao-Ming Wang, R. Mannan, Lan-Bo Xiao, E. Abdulfatah, Y. Qiao, C. Farver, J. Myers, Sylvia Zelenka-Wang, Lisa McMurry, Feng-Yun Su et al. · 2021 · Communications Medicine
  89. AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 EUA and LDT Serologic Testing in Clinical Laboratories.
    Y. V. Zhang, J. Wiencek, Qing H. Meng, E. Theel, N. Babic, L. Sepiashvili, N. Pecora, P. Slev, A. Cameron, D. Konforte · 2021 · Clinical Chemistry
  90. Ebolavirus: Comparison of Survivor Immunology and Animal Models in the Search for a Correlate of Protection
    Stéphanie Longet, Jack Mellors, Miles W. Carroll, Tom Tipton · 2021 · Frontiers in Immunology
  91. Reinfection, recurrence, or delayed presentation of COVID-19? Case series and review of the literature
    F. Elzein, A. Ibrahim, F. Alshahrani, M. Mahrous, E. Murshid, Turki Aldhehyan, Ghadah Almutiri, Meshal Altowairqi, Medina A. Ahmed, Mohammed Alsaeed et al. · 2021 · Journal of Infection and Public Health
  92. Immunity and infectivity in covid-19
    C. Johnston, Harriet Hughes, S. Lingard, Stephen Hailey, B. Healy · 2022 · British medical journal
  93. Cell and Animal Models for SARS-CoV-2 Research
    Eloïne Bestion, P. Halfon, S. Mezouar, J. Mege · 2022 · Viruses
  94. Drosophila, a powerful model to study virus-host interactions and pathogenicity in the fight against SARS-CoV-2
    J. van de Leemput, Zhe Han · 2021 · Cell & Bioscience
  95. Evaluation of Three SARS CoV-2 IgG Antibody Assays and Correlation with Neutralizing Antibodies
    J. Rychert, M. Couturier, M. Elgort, B. Lozier, La, S. Ulu, J. Genzen, J. Straseski, J. Delgado, P. Slev · 2020 · The Journal of Applied Laboratory Medicine
  96. Canadian society of clinical chemists (CSCC) interim consensus guidance for testing and reporting of SARS-CoV-2 serology
    D. Bailey, D. Konforte, V. Barakauskas, P. Yip, V. Kulasingam, M. Abouelhassan, Lori A. Beach, I. Blasutig, P. Catomeris, K. Dooley et al. · 2020 · Clinical Biochemistry
  97. COVID‐19: Clinical status of vaccine development till date
    Sunny Kumar, Malini Basu, Pratyasha Ghosh, Aafreen Ansari, M. Ghosh · 2022 · British Journal of Clinical Pharmacology
  98. SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection
    Arbor G. Dykema, Boyang Zhang, Bezawit A. Woldemeskel, Caroline C. Garliss, Rufiaat Rashid, Timothy Westlake, Li Zhang, Jiajia Zhang, Laurene S. Cheung, Justina X. Caushi et al. · 2022 · EBioMedicine
  99. Characterisation of Particle Size and Viability of SARS-CoV-2 Aerosols from a Range of Nebuliser Types Using a Novel Sampling Technique
    S. Paton, Simon Clark, A. Spencer, I. Garratt, Ikshitaa Dinesh, Katy-Anne Thompson, A. Bennett, T. Pottage · 2022 · Viruses
  100. An update on host immunity correlates and prospects of re-infection in COVID-19
    Neema Negi, Shesh Prakash Maurya, Ravinder Singh, Bimal Kumar Das · 2021 · International Reviews of Immunology